Skip to main content
UTI
NYSE Trade & Services

CEO Sells Over $2 Million in Company Stock for Tax Planning

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Education Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$37.4
Mkt Cap
$2.058B
52W Low
$21.29
52W High
$37.57
52W Position info
76% above low
Off High info
at 52W high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

UTI sits 76% above its 52-week low of $21.29.

Summary

The CEO of Universal Technical Institute Inc. sold over $2 million worth of shares, citing personal tax planning, amidst the stock trading near its 52-week high.


Key Events · Ownership and Investor Activity · UTI

  • CEO Sells Significant Stake

    Jerome Alan Grant, Chief Executive Officer and Director, disposed of 60,040 shares of common stock in an open market sale for a total value of $2,098,494.

  • Sale for Tax Planning

    The transaction was reported as being for personal tax planning purposes.

  • Stock Trading Near 52-Week High

    This sale occurred on February 27, 2026, with an average price of $34.95 per share, while the company's stock is currently trading near its 52-week high of $37.57.

  • Continuation of Insider Distribution

    This sale contributes to a recent pattern of net insider distribution, with $52,635 in net sales by insiders over the last 90 days prior to this filing.


Analysis · UTI · Trade & Services

Jerome Alan Grant, CEO and Director of Universal Technical Institute Inc., executed a significant open market sale of common stock. While the filing states the sale was for personal tax planning purposes, it represents a substantial disposition by a key executive, occurring while the company's stock is trading near its 52-week high. This transaction contributes to a recent pattern of net insider distribution over the last 90 days, which could be interpreted as a lack of conviction despite the stated reason.

At the time of this filing, UTI was trading at $37.40 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $21.29 to $37.57. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UTI - Latest Insights

UTI
Jun 30, 2026, 8:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $42.77
Real-time Price: $39.09 info
Change: -$3.68 (-9%) info
Market Cap: $2.153B info
UTI
Jun 29, 2026, 4:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.35
Real-time Price: $39.09 info
Change: -$2.26 (-5%) info
Market Cap: $2.153B info
UTI
Jun 10, 2026, 5:59 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $39.55
Real-time Price: $39.09 info
Change: -$0.460 (-1%) info
Market Cap: $2.153B info
UTI
Jun 10, 2026, 5:52 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $39.55
Real-time Price: $39.09 info
Change: -$0.460 (-1%) info
Market Cap: $2.153B info
UTI
Jun 08, 2026, 6:42 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $41.00
Real-time Price: $39.09 info
Change: -$1.91 (-5%) info
Market Cap: $2.153B info